IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,040 | +252.0% | 1,000 | +300.0% | 0.00% | +50.0% |
| Q3 2022 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $3,000 | -95.8% | 250 | -94.3% | 0.00% | -96.4% |
| Q1 2022 | $72,000 | +60.0% | 4,350 | +85.1% | 0.03% | +40.0% |
| Q4 2021 | $45,000 | -57.9% | 2,350 | -46.0% | 0.02% | -59.2% |
| Q3 2021 | $107,000 | -3.6% | 4,350 | +2.4% | 0.05% | -7.5% |
| Q2 2021 | $111,000 | -12.6% | 4,250 | +6.2% | 0.05% | -8.6% |
| Q1 2021 | $127,000 | -31.4% | 4,000 | 0.0% | 0.06% | -31.8% |
| Q4 2020 | $185,000 | +39.1% | 4,000 | -1.2% | 0.08% | +13.3% |
| Q3 2020 | $133,000 | +19.8% | 4,050 | 0.0% | 0.08% | +8.7% |
| Q2 2020 | $111,000 | -0.9% | 4,050 | 0.0% | 0.07% | -5.5% |
| Q4 2019 | $112,000 | – | 4,050 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |